First of all, hi Donna405 and RobertBianchi. It is good to see some activity here, I was beginning to think that I was the only left looking at this board.Why do you think that the cure rates are so low?It seems that the problem people are having with the data that has been recently released is that they did not include any data on "biological activity."As I understand it, and I am way over my head here, the recent data is from a Phase 1 study. These studies are determine what happens with the drug in a human body. They are not looking at cure rates at this point, more at what the drug does when it is in a human body.Some info taken from:http://www.fool.com/specials/2000/sp000405fda.htmIt seems that things went well for the first phase. I didn't find any bad news, just the lack of any blockbuster news.At this point, I'm continuing to hold my position. The drop in stock price alone isn't reason for me to sell, I'm trying to keep my focus on the technology and the company. And although things are going slowly, they do seem to be progressing.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat